Pembrolizumab as a first-line treatment for advanced gastric cancer

被引：2
|
作者：
Chau, Ian [1 ]
机构：
[1] Royal Marsden Hosp, Dept Med, Sutton, England
来源：
LANCET ONCOLOGY | 2023年 / 24卷 / 11期
关键词：
D O I：
10.1016/S1470-2045(23)00526-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1158 / 1159
页数：2
相关论文
共 50 条
  • [31] New first-line treatment for gastric/GEJ cancer
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (04): : 291 - 291
  • [32] Bevacizumab in the First-line Treatment of advanced Ovarian Cancer
    Mallmann, Michael R.
    Alakus, Hakan
    Mallmann, Peter
    Bruns, Christiane
    ONKOLOGE, 2019, 25 (11): : 1020 - 1021
  • [33] The real-word evidence of first-line treatment of pembrolizumab in advanced NSCLC.
    Li, Pin
    Gadgeel, Shirish M.
    Poisson, Laila
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [34] A Review About Pembrolizumab in First-Line Treatment of Advanced NSCLC: Focus on KEYNOTE Studies
    Qu, Jialin
    Wang, Li
    Jiang, Man
    Zhao, Deze
    Wang, Yuyang
    Zhang, Feng
    Li, Jing
    Zhang, Xiaochun
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 6493 - 6509
  • [35] Docetaxel and S-1 as a First-line Treatment in Patients with Advanced or Recurrent Gastric Cancer
    Tsutani, Yasuhiro
    Ohara, Masahiro
    Suzuki, Takahisa
    Minami, Kazuhito
    Miyahara, Eiji
    Kameda, Akira
    Noso, Yoshihiro
    ANTICANCER RESEARCH, 2009, 29 (07) : 2775 - 2779
  • [36] FOLFOX-4 Combination Chemotherapy as a First-Line Treatment in Patients With Advanced Gastric Cancer
    Kim, Bu Kyung
    Jeong, Su Hyeon
    Park, Moo-In
    Park, Seun Ja
    Kim, Kyu Jong
    Moon, Won
    Shin, Eun Kyung
    Lee, Jee Suk
    GASTROENTEROLOGY, 2010, 138 (05) : S442 - S442
  • [37] Effects of Oteracil Combined with Oxaliplatin as First-Line Treatment in Elderly Patients with Advanced Gastric Cancer
    Fan, W. F.
    Wang, J.
    Meng, L. J.
    Liu, F. Y.
    Pu, X. L.
    Yang, M.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2013, 61 : S315 - S315
  • [38] The comparison of mFOLFOX-6, mDCF, mFOLFIRINOX in the first-line treatment of advanced gastric cancer
    Ignatova, E.
    Fedyanin, M.
    Pokataev, I.
    Tryakin, A.
    Popova, A.
    Bazin, I.
    Chekini, D.
    Sekhina, O.
    Lyadova, M.
    Rumyantsev, A.
    Nikulin, V.
    Vakhabova, Y.
    Moiseenko, F.
    Chubenko, V.
    Tjulandin, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S181 - S181
  • [39] Pembrolizumab for the first-line treatment of non-small cell lung cancer
    Ninomiya, Kiichiro
    Hotta, Katsuyuki
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (10) : 1015 - 1021
  • [40] POSTPROGRESSION SURVIVAL FOR FIRST-LINE CHEMOTHERAPY IN PATIENTS WITH ADVANCED GASTRIC CANCER
    Kawakami, H.
    Okamoto, I.
    Hayashi, H.
    Taguri, M.
    Morita, S.
    Nakagawa, K.
    ANNALS OF ONCOLOGY, 2012, 23 : 95 - 95
12345